Detalhe da pesquisa
1.
How can we improve the management of vascular risk in type 2 diabetes: insights from FIELD.
Cardiovasc Drugs Ther
; 23(5): 403-8, 2009 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-19757004
2.
Human Bone Marrow Endothelial Progenitor Cell Transplantation into Symptomatic ALS Mice Delays Disease Progression and Increases Motor Neuron Survival by Repairing Blood-Spinal Cord Barrier.
Sci Rep
; 9(1): 5280, 2019 03 27.
Artigo
Inglês
| MEDLINE | ID: mdl-30918315
3.
Reduction of microhemorrhages in the spinal cord of symptomatic ALS mice after intravenous human bone marrow stem cell transplantation accompanies repair of the blood-spinal cord barrier.
Oncotarget
; 9(12): 10621-10634, 2018 Feb 13.
Artigo
Inglês
| MEDLINE | ID: mdl-29535831
4.
Atherosclerosis in type 2 diabetes: a role for fibrate therapy?
Diab Vasc Dis Res
; 4(4): 368-74, 2007 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-18158710
5.
Endothelial and Astrocytic Support by Human Bone Marrow Stem Cell Grafts into Symptomatic ALS Mice towards Blood-Spinal Cord Barrier Repair.
Sci Rep
; 7(1): 884, 2017 04 13.
Artigo
Inglês
| MEDLINE | ID: mdl-28408761
6.
Statement of the problem.
Am J Cardiol
; 97(12A): 3G-8G, 2006 Jun 19.
Artigo
Inglês
| MEDLINE | ID: mdl-16813733
7.
Fenofibrate, HDL, and cardiovascular disease in Type-2 diabetes: The DAIS trial.
Atherosclerosis
; 247: 35-39, 2016 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-26854974
8.
Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS).
Circulation
; 107(13): 1733-7, 2003 Apr 08.
Artigo
Inglês
| MEDLINE | ID: mdl-12665498
9.
Fibrates and coronary risk reduction.
Atherosclerosis
; 182(2): 199-207, 2005 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-15894321
10.
Fenofibrate reduces progression to microalbuminuria over 3 years in a placebo-controlled study in type 2 diabetes: results from the Diabetes Atherosclerosis Intervention Study (DAIS).
Am J Kidney Dis
; 45(3): 485-93, 2005 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-15754270
11.
Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene.
Arterioscler Thromb Vasc Biol
; 23(4): 644-9, 2003 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-12692006
12.
A new perspective in the treatment of dyslipidemia : can fenofibrate offer unique benefits in the treatment of type 2 diabetes mellitus?
Treat Endocrinol
; 4(5): 311-7, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-16185099
13.
Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.
J Clin Endocrinol Metab
; 89(8): 3949-55, 2004 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-15292332
14.
Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes.
Pharmacogenetics
; 14(12): 823-9, 2004 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-15608561
15.
Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia.
Atherosclerosis
; 177(1): 137-45, 2004 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-15488876
16.
Fibrates in the metabolic syndrome and in diabetes.
Endocrinol Metab Clin North Am
; 33(3): 545-55, vi-vii, 2004 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-15262296
17.
Effect of fenofibrate-mediated increase in plasma homocysteine on the progression of coronary artery disease in type 2 diabetes mellitus.
Am J Cardiol
; 93(7): 848-53, 2004 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15050487
18.
Appropriate revascularization in stable angina: lessons from the BARI 2D trial.
Can J Cardiol
; 30(12): 1595-601, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25475464
19.
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group II: pathogenesis of atherosclerosis in diabetes.
Circulation
; 105(18): e138-43, 2002 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-11994264
20.
Fenofibrate lowers plasma triglycerides and increases LDL particle diameter in subjects with type 2 diabetes.
Diabetes Care
; 25(3): 627-8, 2002 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-11874962